S
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Price:
27.81
CNY
2.17%
Market Cap:
¥1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
Sanki Engineering Co Ltd
TSE:1961
|
JP |
|
Ulusoy Elektrik Imalat Taahhut ve Ticaret AS
IST:ULUSE.E
|
TR |
|
Photo-Me International PLC
LSE:PHTM
|
UK |
|
ADM Tronics Unlimited Inc
OTC:ADMT
|
US |
|
Hexcel Corp
NYSE:HXL
|
US |
Multiples-Based Value
The Multiples-Based Value of one Shanghai Rightongene Biotechnology Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 27.81 CNY, Shanghai Rightongene Biotechnology Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shanghai Rightongene Biotechnology Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Shanghai Rightongene Biotechnology Co Ltd Competitors
Shanghai Rightongene Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
1.6B CNY | 7.3 | -72.7 | -38.5 | -38.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
